COVID-19 vaccine
A COVID‑19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2), the virus that causes coronavirus disease 2019 (COVID‑19).
In Phase III trials, several COVID‑19 vaccines have demonstrated efficacy as high as 95% in preventing symptomatic COVID‑19 infections.
This kind of claim shows how unrealistic and far from reality the vaccination proponents really are. Their realism is exclusively financial in nature. They are getting very wealthy, but for that, they had to delve in skulduggery, starting with gain-of-function research and therapeutic nihilism, to bring millions to their deaths, just to protect their dream of unprecedented wealth and power.
Then they had to sabotage the discoveries made by frontline doctors all over the world, blocking or sabotaging any cheap medication that medical workers developed.
All proposed studies of ivermectin as prophylaxis have been blocked, just as the studies of vitamin D as prophylaxis for respiratory infections have been blocked by the WHO, for more than ten years.
Together with studies of the curative effectiveness of ivermectin, because it works too well. With a safety record proved by 3 billion deliveries, mostly in Africa, ivermectin provides prophylaxis without the danger of paralysis, dementia, or death. The problem is the cost: any company, in any country can make ivermectin.
As multiple COVID-19 vaccines have been authorized or licensed for use, real-world vaccine effectiveness (RWE) is now being assessed using case control and observational studies.[30]
A study is investigating the long-lasting protection against SARS-CoV-2 provided by the mRNA vaccines.[31]
Pfizer and BioNTech’s Covid-19 vaccine is just 39% effective in Israel where the delta variant is the dominant strainhttps://www.cnbc.com/2021/07/23/delta-variant-pfizer-covid-vaccine-39percent-effective-in-israel-prevents-severe-illness.html
See the detailed chart under the heading "Covid-19 Vaccine Efficacy"
On 10 August, a study showed that the full vaccination coverage rate is correlated inversely to the SARS-CoV-2 delta variant mutation frequency in 16 countries (R-squared=0.878).[32]
[32]. Abstract
Public distrust has undermined COVID-19 vaccine acceptance and has become a major public health issue in the battle against SARS-CoV-2 transmission globally. Here we present the first evidence that the vaccination coverage rate is inversely correlated to the mutation frequency of the SARS-CoV-2 delta variant in 16 countries (R2=0.878), strongly indicating that full vaccination against COVID-19 is critical to suppress emergent mutations.
... We recommend that universal vaccination, as well as mitigation strategies, and genomic surveillance continue to be employed to prevent further viral transmission.
In simpler words, the thesis is that less virus mutations are discovered in countries where vaccination is more common; thus, we must rush ahead towards full vaccination, to prevent the rise of new variants.
This is a desire shared by all men of good will. All humans also desire happy long lives, followed by a very very long residence in Paradise. Unfortunately...
Universal effective vaccination cannot control the development of variants because it's a pipe dream.
The vaccine effectiveness data from Israel show that universal effective vaccination in the West is a fantasy. It's an impossible dream in the West. To pretend that it be achievable in Asia and Africa is to insult our intelligence. The deadlier variants will have all opportunities to develop in the rest of the world.
The only way to obtain control of variants' development is rational use of available very cheap prophylaxis--vitamin D, vitamin C, zinc, ivermectin. Also quercetin, Nigella sativa seeds, Sambucus nigra berries (elderberries).
The problem is that the profits obtainable from easy-to-cultivate plants and from medications out of patent is not attractive to the oligarchy. The nine new Big Pharma billionaires, all created in 2020, are now able to buy politicians, newspapers, and TV stations. They are not interested in controlling the development of variants.